Premium
Absolute bioavailability of terbutaline from a CR‐granulate in asthmatic children
Author(s) -
Fuglsang Gunver,
Hertz Birgitte,
Holm Eva Bettina,
Borgström Lars
Publication year - 1990
Publication title -
biopharmaceutics and drug disposition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.419
H-Index - 58
eISSN - 1099-081X
pISSN - 0142-2782
DOI - 10.1002/bdd.2510110109
Subject(s) - terbutaline , bioavailability , pharmacokinetics , oral administration , concomitant , elixir (programming language) , medicine , chemistry , pharmacology , anesthesia , chromatography , asthma , computer science , programming language
The study aimed at finding the absolute bioavailability of terbutaline of a newly developed CR‐granulate. Eight asthmatic children, aged 8–13 years, were given 3 mg of terbutaline as the CR‐granulate, concomitant with the intravenous administration of 0·100 mg of deuterium‐labelled terbutaline. The labelling of the intravenous dose made possible a separation, in the analytical step, of terbutaline originating from the intravenous and oral administration. Maximal plasma concentration, 8·7 (range: 4·9–15·2) nmoll −1 , was reached after 4·7 (2·2–6·0) h. Absolute bioavailability was 10·8 (7·63–16·4) per cent. The parameter values were similar to those found after administration of terbutaline CR‐tablets to adults. The CR‐formulation is easily swallowed and can be dosed twice daily. Thus it should be a good alternative to elixir or plain tablets, dosed three times a day.